Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tricetin is a naturally occurring flavone (a type of flavonoid) found in certain plants such as the pollen of Myrtaceae family members and in some cereals and teas. It is characterized by its pentahydroxylated structure. Tricetin has demonstrated notable biological activities including anti-inflammatory and anticancer effects. In vitro studies show that it inhibits proliferation of human breast adenocarcinoma MCF-7 cells in a dose-dependent manner. Its anti-inflammatory action has been linked to radical scavenging properties and inhibition of poly (ADP-ribose) polymerase-1 (PARP1), which plays a role in DNA damage response and inflammation[2][7]. Tricetin is not an approved pharmaceutical drug but is studied for its potential health benefits as a dietary flavonoid.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tricetin.